ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,085 | +19.3% | 60,566 | +46.8% | 0.00% | 0.0% |
| Q2 2023 | $276,794 | -50.8% | 41,251 | -35.3% | 0.00% | -50.0% |
| Q1 2023 | $562,877 | -8.3% | 63,746 | -26.1% | 0.00% | -50.0% |
| Q3 2022 | $614,000 | +19.9% | 86,280 | +36.2% | 0.00% | 0.0% |
| Q2 2022 | $512,000 | -31.3% | 63,340 | +18.0% | 0.00% | -33.3% |
| Q1 2022 | $745,000 | -15.1% | 53,671 | +146.5% | 0.01% | -57.1% |
| Q1 2021 | $877,000 | – | 21,777 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 15,115,090 | $419,897,000 | 10.74% |
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $30,986,000 | 10.41% |
| Robertson Stephens Wealth Management, LLC | 537,095 | $14,920,000 | 5.10% |
| VIKING GLOBAL INVESTORS LP | 33,493,708 | $930,455,000 | 4.84% |
| Senator Investment Group LP | 3,388,085 | $94,121,000 | 3.41% |
| Casdin Capital, LLC | 793,125 | $22,033,000 | 2.34% |
| Iron Triangle Partners LP | 150,000 | $4,167,000 | 1.61% |
| Aristotle Atlantic Partners, LLC | 370,841 | $10,302,000 | 1.57% |
| Crewe Advisors LLC | 93,000 | $2,584,000 | 1.54% |
| PERSONAL CFO SOLUTIONS, LLC | 112,916 | $3,137,000 | 1.13% |